This manual provides usage instructions, dosage, contraindications, and side effects for Sodium Monosialotettrahexosylganglioside Injection (2ml:20mg) by…
This document is the official instruction manual for Sodium Monosialotettrahexosylganglioside Injection, manufactured by Changchun Xiangtong Pharmaceutical Co., Ltd. It details the drug's indications for treating vascular or traumatic central nervous system damage and Parkinson's disease, along with specific dosage regimens for acute conditions and chronic management.
The manual outlines critical safety information, including contraindications for patients with genetic lipid metabolism disorders or Guillain-Barre syndrome. It also lists potential adverse reactions such as skin rashes, respiratory distress, and neurological symptoms, advising immediate medical attention if specific symptoms like paralysis or limb weakness occur within 5-10 days of use. This manual is written in Chinese.
| Molecular Weight | 1568.84 or 1597.18 |
|---|---|
| Dosage Form | Injection |
| Specification | 2ml:20mg |
| Shelf Life | 36 months |
| Packaging | 5 ampoules per box |
It is used to treat vascular or traumatic central nervous system damage and Parkinson's disease.
The daily dose is 100mg via intravenous drip during the acute phase, changing to a maintenance dose of 20-40mg after 2-3 weeks.
If patients experience inability to hold objects, limb weakness, or flaccid paralysis within 5-10 days of use, they should seek medical help immediately.